Fetal vs adult megakaryopoiesis

Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as “immaturity.” However, more recent studies have demonstrated tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-06, Vol.139 (22), p.3233-3244
Hauptverfasser: Davenport, Patricia, Liu, Zhi-Jian, Sola-Visner, Martha
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3244
container_issue 22
container_start_page 3233
container_title Blood
container_volume 139
creator Davenport, Patricia
Liu, Zhi-Jian
Sola-Visner, Martha
description Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as “immaturity.” However, more recent studies have demonstrated that the small, low-ploidy fetal and neonatal megakaryocytes have all the characteristics of adult polyploid megakaryocytes, including the presence of granules, a well-developed demarcation membrane system, and proplatelet formation. Thus, rather than immaturity, the features of fetal and neonatal megakaryopoiesis reflect a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation, which allows fetuses and neonates to populate their rapidly expanding bone marrow and blood volume. At the molecular level, the features of fetal and neonatal megakaryopoiesis are the result of a complex interplay of developmentally regulated pathways and environmental signals from the different hematopoietic niches. Over the past few years, studies have challenged traditional paradigms about the origin of the megakaryocyte lineage in both fetal and adult life, and the application of single-cell RNA sequencing has led to a better characterization of embryonic, fetal, and adult megakaryocytes. In particular, a growing body of data suggests that at all stages of development, the various functions of megakaryocytes are not fulfilled by the megakaryocyte population as a whole, but rather by distinct megakaryocyte subpopulations with dedicated roles. Finally, recent studies have provided novel insights into the mechanisms underlying developmental disorders of megakaryopoiesis, which either uniquely affect fetuses and neonates or have different clinical presentations in neonatal compared with adult life. [Display omitted]
doi_str_mv 10.1182/blood.2020009301
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9164738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122001446</els_id><sourcerecordid>2625272892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-3d21ee89dbf735496ac80c115aed4b715a8193383e56c675bf02f8fa8840aeb03</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EoqWwM0FHloA_E4cBCVUUkCqxwGw59qUYkrrYSSX-ewwtBQamJ7179-70Q-iY4HNCJL2oGu_tOcUUY1wyTHbQkAgqM5ycXTRMbp7xsiADdBDjC8aEMyr20YAJgiUTbIhOp9DpZryKY237phu3MNevOrz7pXcQXTxEe7VuIhxtdISepjePk7ts9nB7P7meZYbzosuYpQRAlraqCyZ4mWsjsSFEaLC8KpJKUjImGYjc5IWoakxrWWspOdZQYTZCV-veZV-1YA0suqAbtQyuTd8or536O1m4ZzX3K1WSnBepeITONgXBv_UQO9W6aKBp9AJ8HxXNqaAFlSVNUbyOmuBjDFBvzxCsPrmqL67qh2taOfn93nbhG2QKXK4DkCCtHAQVjYOFAesCmE5Z7_5v_wDfcIeM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2625272892</pqid></control><display><type>article</type><title>Fetal vs adult megakaryopoiesis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Davenport, Patricia ; Liu, Zhi-Jian ; Sola-Visner, Martha</creator><creatorcontrib>Davenport, Patricia ; Liu, Zhi-Jian ; Sola-Visner, Martha</creatorcontrib><description>Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as “immaturity.” However, more recent studies have demonstrated that the small, low-ploidy fetal and neonatal megakaryocytes have all the characteristics of adult polyploid megakaryocytes, including the presence of granules, a well-developed demarcation membrane system, and proplatelet formation. Thus, rather than immaturity, the features of fetal and neonatal megakaryopoiesis reflect a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation, which allows fetuses and neonates to populate their rapidly expanding bone marrow and blood volume. At the molecular level, the features of fetal and neonatal megakaryopoiesis are the result of a complex interplay of developmentally regulated pathways and environmental signals from the different hematopoietic niches. Over the past few years, studies have challenged traditional paradigms about the origin of the megakaryocyte lineage in both fetal and adult life, and the application of single-cell RNA sequencing has led to a better characterization of embryonic, fetal, and adult megakaryocytes. In particular, a growing body of data suggests that at all stages of development, the various functions of megakaryocytes are not fulfilled by the megakaryocyte population as a whole, but rather by distinct megakaryocyte subpopulations with dedicated roles. Finally, recent studies have provided novel insights into the mechanisms underlying developmental disorders of megakaryopoiesis, which either uniquely affect fetuses and neonates or have different clinical presentations in neonatal compared with adult life. [Display omitted]</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood.2020009301</identifier><identifier>PMID: 35108353</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Bone Marrow ; Fetus ; Humans ; Infant, Newborn ; Megakaryocyte Progenitor Cells ; Megakaryocytes - metabolism ; Megakaryopoiesis and Platelet Production ; Thrombopoiesis - genetics</subject><ispartof>Blood, 2022-06, Vol.139 (22), p.3233-3244</ispartof><rights>2022 American Society of Hematology</rights><rights>2022 by The American Society of Hematology.</rights><rights>2022 by The American Society of Hematology 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-3d21ee89dbf735496ac80c115aed4b715a8193383e56c675bf02f8fa8840aeb03</citedby><cites>FETCH-LOGICAL-c447t-3d21ee89dbf735496ac80c115aed4b715a8193383e56c675bf02f8fa8840aeb03</cites><orcidid>0000-0003-1230-504X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35108353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Davenport, Patricia</creatorcontrib><creatorcontrib>Liu, Zhi-Jian</creatorcontrib><creatorcontrib>Sola-Visner, Martha</creatorcontrib><title>Fetal vs adult megakaryopoiesis</title><title>Blood</title><addtitle>Blood</addtitle><description>Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as “immaturity.” However, more recent studies have demonstrated that the small, low-ploidy fetal and neonatal megakaryocytes have all the characteristics of adult polyploid megakaryocytes, including the presence of granules, a well-developed demarcation membrane system, and proplatelet formation. Thus, rather than immaturity, the features of fetal and neonatal megakaryopoiesis reflect a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation, which allows fetuses and neonates to populate their rapidly expanding bone marrow and blood volume. At the molecular level, the features of fetal and neonatal megakaryopoiesis are the result of a complex interplay of developmentally regulated pathways and environmental signals from the different hematopoietic niches. Over the past few years, studies have challenged traditional paradigms about the origin of the megakaryocyte lineage in both fetal and adult life, and the application of single-cell RNA sequencing has led to a better characterization of embryonic, fetal, and adult megakaryocytes. In particular, a growing body of data suggests that at all stages of development, the various functions of megakaryocytes are not fulfilled by the megakaryocyte population as a whole, but rather by distinct megakaryocyte subpopulations with dedicated roles. Finally, recent studies have provided novel insights into the mechanisms underlying developmental disorders of megakaryopoiesis, which either uniquely affect fetuses and neonates or have different clinical presentations in neonatal compared with adult life. [Display omitted]</description><subject>Adult</subject><subject>Bone Marrow</subject><subject>Fetus</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Megakaryocyte Progenitor Cells</subject><subject>Megakaryocytes - metabolism</subject><subject>Megakaryopoiesis and Platelet Production</subject><subject>Thrombopoiesis - genetics</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1PwzAQxS0EoqWwM0FHloA_E4cBCVUUkCqxwGw59qUYkrrYSSX-ewwtBQamJ7179-70Q-iY4HNCJL2oGu_tOcUUY1wyTHbQkAgqM5ycXTRMbp7xsiADdBDjC8aEMyr20YAJgiUTbIhOp9DpZryKY237phu3MNevOrz7pXcQXTxEe7VuIhxtdISepjePk7ts9nB7P7meZYbzosuYpQRAlraqCyZ4mWsjsSFEaLC8KpJKUjImGYjc5IWoakxrWWspOdZQYTZCV-veZV-1YA0suqAbtQyuTd8or536O1m4ZzX3K1WSnBepeITONgXBv_UQO9W6aKBp9AJ8HxXNqaAFlSVNUbyOmuBjDFBvzxCsPrmqL67qh2taOfn93nbhG2QKXK4DkCCtHAQVjYOFAesCmE5Z7_5v_wDfcIeM</recordid><startdate>20220602</startdate><enddate>20220602</enddate><creator>Davenport, Patricia</creator><creator>Liu, Zhi-Jian</creator><creator>Sola-Visner, Martha</creator><general>Elsevier Inc</general><general>American Society of Hematology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1230-504X</orcidid></search><sort><creationdate>20220602</creationdate><title>Fetal vs adult megakaryopoiesis</title><author>Davenport, Patricia ; Liu, Zhi-Jian ; Sola-Visner, Martha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-3d21ee89dbf735496ac80c115aed4b715a8193383e56c675bf02f8fa8840aeb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Bone Marrow</topic><topic>Fetus</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Megakaryocyte Progenitor Cells</topic><topic>Megakaryocytes - metabolism</topic><topic>Megakaryopoiesis and Platelet Production</topic><topic>Thrombopoiesis - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Davenport, Patricia</creatorcontrib><creatorcontrib>Liu, Zhi-Jian</creatorcontrib><creatorcontrib>Sola-Visner, Martha</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Davenport, Patricia</au><au>Liu, Zhi-Jian</au><au>Sola-Visner, Martha</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal vs adult megakaryopoiesis</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2022-06-02</date><risdate>2022</risdate><volume>139</volume><issue>22</issue><spage>3233</spage><epage>3244</epage><pages>3233-3244</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>Fetal and neonatal megakaryocyte progenitors are hyperproliferative compared with adult progenitors and generate a large number of small, low-ploidy megakaryocytes. Historically, these developmental differences have been interpreted as “immaturity.” However, more recent studies have demonstrated that the small, low-ploidy fetal and neonatal megakaryocytes have all the characteristics of adult polyploid megakaryocytes, including the presence of granules, a well-developed demarcation membrane system, and proplatelet formation. Thus, rather than immaturity, the features of fetal and neonatal megakaryopoiesis reflect a developmentally unique uncoupling of proliferation, polyploidization, and cytoplasmic maturation, which allows fetuses and neonates to populate their rapidly expanding bone marrow and blood volume. At the molecular level, the features of fetal and neonatal megakaryopoiesis are the result of a complex interplay of developmentally regulated pathways and environmental signals from the different hematopoietic niches. Over the past few years, studies have challenged traditional paradigms about the origin of the megakaryocyte lineage in both fetal and adult life, and the application of single-cell RNA sequencing has led to a better characterization of embryonic, fetal, and adult megakaryocytes. In particular, a growing body of data suggests that at all stages of development, the various functions of megakaryocytes are not fulfilled by the megakaryocyte population as a whole, but rather by distinct megakaryocyte subpopulations with dedicated roles. Finally, recent studies have provided novel insights into the mechanisms underlying developmental disorders of megakaryopoiesis, which either uniquely affect fetuses and neonates or have different clinical presentations in neonatal compared with adult life. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35108353</pmid><doi>10.1182/blood.2020009301</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-1230-504X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-06, Vol.139 (22), p.3233-3244
issn 0006-4971
1528-0020
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9164738
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Bone Marrow
Fetus
Humans
Infant, Newborn
Megakaryocyte Progenitor Cells
Megakaryocytes - metabolism
Megakaryopoiesis and Platelet Production
Thrombopoiesis - genetics
title Fetal vs adult megakaryopoiesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A11%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20vs%20adult%20megakaryopoiesis&rft.jtitle=Blood&rft.au=Davenport,%20Patricia&rft.date=2022-06-02&rft.volume=139&rft.issue=22&rft.spage=3233&rft.epage=3244&rft.pages=3233-3244&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood.2020009301&rft_dat=%3Cproquest_pubme%3E2625272892%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2625272892&rft_id=info:pmid/35108353&rft_els_id=S0006497122001446&rfr_iscdi=true